Intensive Insulin Treatment and Ischemic Foot Ulcer
Ischemic Foot Ulcer
About this trial
This is an interventional treatment trial for Ischemic Foot Ulcer focused on measuring HbA1c, Iontophoresis, Intensified insulin treatment, Ischemic foot ulcer, Type 1 diabetes
Eligibility Criteria
Inclusion Criteria:
Born 1930 or later, Type 1 diabetes appearing at age 30 or earlier and with insulin dependency within 1 year from diagnosis, no known abuse of alcohol or drugs, non-prolipherative retinopathy of any degree present, no previous photocoagulation, normal serum creatinine, unsatsifactory blood glucose control according to the physician in charge of the patients.
Exclusion Criteria:
Any history or ongoing ischemic foot ulcer,or peripheral artery disease,or osteoartropathy.
Sites / Locations
- Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset
- Karolinska Institutet, Division of Internal Medicine Södersjukhuset AB
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
No Intervention
Intensified insulin treatment
Standard treatment
Healthy controls
Basal (Monotard) insulin; ones a day Bolus (Actrapid) insulin; thrice a day
Mixed Insulin (2-3 times a day)
These people were solely controls for the iontophoresis method used in the study. With no intervention or follow-up-